Different diabetes drugs have different efficacies for reducing the HbA1c; for example, insulin has the highest efficacy, GLP-1 RAs, TZD and sulfonylureas have high efficacy, SGLT2i and DPP-4i has an intermediate efficacy. The gene discussed is INS; the disease is diabetes mellitus.